GILD congressional trades
Gilead Sciences, Inc. (GILD) appears in 19 congressional disclosure rows from 9 members of Congress in 2025–2026 periodic reports: 14 purchases and 5 sales, with trade dates from May 8, 2024 to May 6, 2026. Tommy Tuberville reported the most, with 4 rows. The median gap between trade date and filing date is 34 days, and 6 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live GILD portfolio or a trading signal.
- 19
- 9
- 14 / 5
- $47K – $355K
- sum of reported ranges
- 2026-05-06
Verified GILD congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 14 purchases and 5 sales. Reported owners: Dependent, Self, Joint, Spouse. Transaction dates run from 2024-05-08 to 2026-05-06.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Jared Moskowitz | Gilead Sciences, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20034749 Filed 2026-06-19 | |
| Jared Moskowitz | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20034749 Filed 2026-06-19 | |
| Alan Armstrong | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Josh Gottheimer | Gilead Sciences, Inc. - Common Stock | Purchase | Joint | $1,001 - $15,000 | #20033930 Filed 2026-02-26 | |
| Valerie Hoyle | Gilead Sciences, Inc. - Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Marjorie Greene | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20030539 Filed 2025-06-18 | |
| Josh Gottheimer | Gilead Sciences, Inc. - Common Stock | Sale | Joint | $1,001 - $15,000 | #20030462 Filed 2025-06-11 | |
| Jefferson Shreve | Gilead Sciences, Inc. - Common Stock | Sale | Self | $15,001 - $50,000 | #20030387 Filed 2025-06-22 | |
| Marjorie Greene | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| Marjorie Greene | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| John Boozman | Gilead Sciences Inc | Sale | Joint | $1,001 - $15,000 | #52c9fa8c-a4fa-4f74-9013-0e1076574cfa Filed 2025-05-14 | |
| Jefferson Shreve | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $15,001 - $50,000 | #20029038 Filed 2025-04-11 | |
| Carol Miller | Gilead Sciences, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20029135 Filed 2025-04-11 | |
| Josh Gottheimer | Gilead Sciences, Inc. - Common Stock | Purchase | Joint | $1,001 - $15,000 | #20029083 Filed 2025-04-10 | |
| Valerie Hoyle | Gilead Sciences, Inc. - Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Tommy Tuberville | Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024 | Purchase | Joint | $1,001 - $15,000 | #0a25588d-a3f8-4ed6-971a-706097f78e3a Filed 2026-08-05 | |
| Tommy Tuberville | Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024 | Purchase | Joint | $1,001 - $15,000 | #0a25588d-a3f8-4ed6-971a-706097f78e3a Filed 2026-08-05 | |
| Tommy Tuberville | Gilead Sciences Inc Option Type: Put Strike price: $70.00 Expires: 11/15/2024 | Purchase | Joint | $1,001 - $15,000 | #0a25588d-a3f8-4ed6-971a-706097f78e3a Filed 2026-08-05 | |
| Tommy Tuberville | Gilead Sciences, Inc. - Common Stock | Sale | Joint | $1,001 - $15,000 | #0a25588d-a3f8-4ed6-971a-706097f78e3a Filed 2026-08-05 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
GILD disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Tommy Tuberville's GILD trades | 4 | 3 | 1 | 2024-05-10 |
| Josh Gottheimer's GILD trades | 3 | 2 | 1 | 2026-01-27 |
| Marjorie Greene's GILD trades | 3 | 3 | 0 | 2025-06-06 |
| Jared Moskowitz | 2 | 2 | 0 | 2026-05-06 |
| Jefferson Shreve | 2 | 1 | 1 | 2025-05-12 |
| Valerie Hoyle | 2 | 1 | 1 | 2025-09-23 |
| Alan Armstrong | 1 | 1 | 0 | 2026-03-27 |
| Carol Miller | 1 | 1 | 0 | 2025-03-10 |
| John Boozman | 1 | 0 | 1 | 2025-04-16 |
How long disclosure took
Days from trade date to filing date for 19 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 4
- 16–30 days
- 4
- 31–45 days
- 5
- Over 45 days
- 6
- Median / longest
- 34d / 819d
Source documents
14 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #0a25588d-a3f8-4ed6-971a-706097f78e3aFiled 2026-08-05 · 4 rows
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20034749Filed 2026-06-19 · 2 rows
- #20033930Filed 2026-02-26 · 1 row
- #20032211Filed 2025-10-10 · 1 row
- #20032070Filed 2025-09-12 · 1 row
- #20030387Filed 2025-06-22 · 1 row
- #20030539Filed 2025-06-18 · 1 row
- #20030462Filed 2025-06-11 · 1 row
- #52c9fa8c-a4fa-4f74-9013-0e1076574cfaFiled 2025-05-14 · 1 row
- #20030295Filed 2025-05-06 · 2 rows
- #20029038Filed 2025-04-11 · 1 row
2 older filings are linked from the transaction table.
What GILD filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Gilead Sciences, Inc. financials and filings
Audited SEC figures, what moves GILD, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
GILD congressional trades: FAQ
Who in Congress traded GILD?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 19 verified GILD rows from 9 members: Alan Armstrong, Carol Miller, Jared Moskowitz, Jefferson Shreve, and 5 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current GILD holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are GILD amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is GILD congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (177 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded GILD.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-10-09. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported GILD and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included